Ramdevbaba Solvent Ltd
Founded in 2008, Ramdevbaba Solvent Limited produces and distributes physically refined rice bran oil.[1]
- Market Cap ₹ 174 Cr.
- Current Price ₹ 76.2
- High / Low ₹ 143 / 58.8
- Stock P/E 12.0
- Book Value ₹ 72.6
- Dividend Yield 0.00 %
- ROCE 11.2 %
- ROE 9.12 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.05 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.8% over last 3 years.
- Earnings include an other income of Rs.8.61 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Edible Oil
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 105 | 124 | 349 | 424 | 583 | 698 | 686 | 928 | 821 | |
| 104 | 123 | 337 | 410 | 566 | 679 | 661 | 903 | 796 | |
| Operating Profit | 1 | 1 | 12 | 13 | 17 | 19 | 25 | 26 | 26 |
| OPM % | 1% | 1% | 3% | 3% | 3% | 3% | 4% | 3% | 3% |
| 0 | 0 | 1 | 2 | 2 | 9 | 7 | 7 | 9 | |
| Interest | 0 | 0 | 3 | 4 | 5 | 6 | 10 | 8 | 9 |
| Depreciation | 0 | 0 | 3 | 4 | 5 | 2 | 4 | 5 | 5 |
| Profit before tax | 1 | 1 | 6 | 7 | 9 | 19 | 18 | 20 | 20 |
| Tax % | 0% | 0% | 19% | 19% | 22% | 24% | 26% | 25% | 26% |
| 1 | 1 | 5 | 6 | 7 | 15 | 13 | 15 | 14 | |
| EPS in Rs | 27.64 | 19.79 | 110.75 | 125.57 | 145.19 | 320.25 | 8.04 | 6.57 | 6.33 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 6% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 0% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -45% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 13% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 4 | 5 | 5 | 5 | 16 | 23 | 23 | |
| Reserves | 1 | 3 | 24 | 31 | 43 | 57 | 129 | 143 | |
| 14 | 12 | 45 | 65 | 99 | 111 | 94 | 106 | ||
| 6 | 9 | 26 | 28 | 44 | 46 | 43 | 53 | ||
| Total Liabilities | 24 | 27 | 99 | 129 | 191 | 229 | 289 | 325 | |
| 14 | 12 | 39 | 40 | 62 | 94 | 96 | 117 | ||
| CWIP | 0 | 0 | 0 | 12 | 28 | 3 | 13 | 0 | |
| Investments | 0 | 0 | 0 | 0 | 0 | 8 | 14 | 14 | |
| 10 | 14 | 60 | 77 | 101 | 125 | 165 | 193 | ||
| Total Assets | 24 | 27 | 99 | 129 | 191 | 229 | 289 | 325 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 4 | 3 | -3 | 3 | 11 | 5 | -12 | 7 | ||
| -8 | -1 | -3 | -18 | -39 | -19 | -24 | -13 | ||
| 3 | -2 | 6 | 15 | 28 | 14 | 39 | 3 | ||
| Net Cash Flow | 0 | 1 | -0 | -0 | 0 | -0 | 3 | -3 | |
| Free Cash Flow | -3 | 3 | -6 | -16 | -29 | -7 | -30 | -6 | |
| CFO/OP | 599% | 534% | -10% | 24% | 69% | 36% | -37% | 43% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 21 | 16 | 17 | 20 | 22 | 13 | 15 | |
| Inventory Days | 39 | 26 | 29 | 40 | 35 | 47 | |||
| Days Payable | 16 | 16 | 19 | 20 | 10 | 17 | |||
| Cash Conversion Cycle | 11 | 21 | 39 | 28 | 31 | 41 | 37 | 44 | |
| Working Capital Days | 12 | 12 | 16 | 16 | 1 | 2 | 9 | 12 | |
| ROCE % | 4% | 16% | 20% | 17% | 13% | 11% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Processor Rank (Solvent Extractors Association of India Award) rank |
|
||||
| DORB (De-oiled Rice Bran / DOC) - Revenue Share % |
|||||
| Refined Rice Bran Oil - Revenue Share % |
|||||
| Trading Sales - Revenue Share % |
|||||
| Installed Refining Capacity MTPA |
|||||
| Installed Solvent Extraction Capacity MTPA |
|||||
| Number of Permanent Employees count |
|||||
Extracted by Screener AI
Documents
Announcements
-
Integrated Filing- Governance
9 July 2026 - Zero investor complaints in Q1 FY27; stake in RBS Renewables rose to 64.82% on 25 June 2026.
-
Outcome of Board Meeting
9 July 2026 - Board allotted 11,37,600 shares on 9 July 2026 from warrant conversion, raising capital to Rs 23.99 crore.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
9 July 2026 - Regulation 74(5) certificate for quarter ended 30 June 2026; shares fully in demat form.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
9 July 2026 - Announces corporate governance regulations are not applicable under Regulation 15(2)(b) for NSE SME listing.
-
Outcome of Board Meeting
24 June 2026 - Board approved acquisition of additional 14% stake in RBS Renewables for Rs 3.64 crore, raising holding to 64.82%.
Business Segments
A) Third Party Manufacturing[1] The Company manufactures, distributes, markets, and sells rice bran oil to FMCG companies like Mother Dairy Fruit & Vegetable Private Limited, Marico Limited, and Empire Spices and Foods Ltd.